A Polish Acute Leukemia Group Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016)
Agnieszka Wierzbowska(Medical University of Lodz), Gail J. Roboz(Cornell University), Marzena Wątek(Holy Cross University), Agnieszka Pluta, Monika Mordak‐Domagała(Cells Therapy (Poland)), Anna Kopińska(Medical University of Silesia), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Anna Czyż(Wroclaw Medical University), Janusz Hałka(Wojskowy Instytut Medycyny Lotniczej), Tomasz Wróbel, Magdalena Czemerska(Medical University of Lodz), Marek Hus(Medical University of Lublin), Kinga Krawiec(Medical University of Lodz), Krzysztof Woźniczka(Medical University of Silesia), Marta Sobas, Agata Obara(Holy Cross University), Katarzyna Dulik(The Maria Sklodowska-Curie National Research Institute of Oncology), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Andi Rustani(NewYork–Presbyterian Hospital), Michael S. Samuel(Cancer Research UK Scotland Institute), Nuria Mencia Trinchant(NewYork–Presbyterian Hospital), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Lidia Gil(Poznan University of Medical Sciences), Maria Bieniaszewska(Gdańsk Medical University), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Krzysztof Gawroński(Medical University of Warsaw), Magdalena Dutka(Gdańsk Medical University), Andrzej Szczepaniak(Poznan University of Medical Sciences), Tomasz Gromek(Medical University of Lublin), Pinkal Desai(Cornell University), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Jerzy Hołowiecki(Medical University of Silesia), Agnieszka Kopacz(University of Rzeszów), Sang‐Min Lee(Seoul National University), Marta Libura(Medical University of Warsaw), Piotr Stelmach(Medical University of Lodz), Ameenah Sukkur(NewYork–Presbyterian Hospital)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k